A Safety and Effectiveness Study of Acetaminophen Extended Release (3900 mg/Day) and Ibuprofen (1200 mg/Day) in the Treatment of Pain Associated With Ankle Sprains.

NCT00261560 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Sprains and Strains
Pain

Interventions

DRUG: acetaminophen

Sponsor

Johnson & Johnson Consumer and Personal Products Worldwide